Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

Update Il y a 4 ans
Reference: NCT00624819

Woman and Man

  • | Country :
  • Poland
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This protocol posting deals with objectives & outcome measures of the extension phase up to 48-50 months post booster vaccination, to assess long-term antibody persistence in children at around 30, 42 and 66 months of age, who received previously 4 doses of pneumococcal conjugate vaccine. The objectives & outcome measures of the primary phase are presented in a separate protocol posting (NCT number = 00307554). This Protocol posting has been updated in order to comply with the FDA AA (Sep 2007).


Inclusion criteria

  • Infections, Streptococcal

Links